AimingMed is a leading biotech company specializing in organoid technology.Our techniques empower oncologist with organoid-based drug sensitivity tests, and our AI algorithm facilitate the selection of the most suitable treatment options for patients.Moreover, we offer drug evaluation models and a high-throughput drug screening platform to pharmaceutical companies, significantly accelerate the new drug development process and optimizing research costs.
Innovation
Dedication
Excellence
Achievement